What is the recommended dose of Avamys (fluticasone furoate) for children over 8 years old with allergic rhinitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Dosage of Avamys (Fluticasone Furoate) for Children Over 8 Years with Allergic Rhinitis

For children over 8 years old with allergic rhinitis, the recommended dose of Avamys (fluticasone furoate) is 2 sprays per nostril once daily (total daily dose of 110 μg). 1

Dosing Guidelines for Fluticasone Furoate

  • For children aged 2-11 years (including those over 8 years), the recommended starting dose is 1-2 sprays per nostril once daily 1
  • For children over 11 years, the standard dose is 2 sprays per nostril once daily 1
  • Once symptoms are controlled, the dose may be reduced to the minimum effective dose for maintenance therapy 1
  • Fluticasone furoate (Avamys/Veramyst) contains 27.5 μg per spray, making the total daily dose 55-110 μg for children 2-11 years 1

Efficacy and Safety Considerations

  • Intranasal corticosteroids are the most effective medications for treating allergic rhinitis, more effective than the combined use of an antihistamine and a leukotriene antagonist 1
  • The onset of therapeutic effect occurs between 3-12 hours after administration, with optimal efficacy reached within days to weeks 1, 2
  • Clinical trials have demonstrated that fluticasone furoate nasal spray is effective and well-tolerated in children with seasonal and perennial allergic rhinitis 3
  • The 110 μg dose provides optimal risk-benefit ratio with statistically significant and clinically meaningful results for all efficacy endpoints 4

Safety Profile in Children

  • Studies have shown that fluticasone furoate has a good safety profile in children with no significant effect on growth at recommended doses 2
  • Unlike beclomethasone dipropionate, which has shown growth suppression at high doses, fluticasone furoate has not demonstrated clinically significant systemic side effects at recommended doses 1, 2
  • Common side effects include epistaxis (nosebleeds), headache, pharyngolaryngeal pain, nasal ulceration, back pain, pyrexia, and cough 1
  • The medication is contraindicated in children with history of hypersensitivity to fluticasone furoate or any components of the formulation 1

Administration Technique

  • The child should be instructed to shake the bottle prior to use 2
  • Have the child blow their nose before using the spray 2
  • Keep the head in an upright position during administration 2
  • Hold the spray in the opposite hand in relation to the nostril being treated (contralateral technique) to reduce risk of epistaxis 2
  • The child should breathe in gently during spraying 2
  • Regular use rather than as-needed approach is recommended for optimal symptom control 1, 2

Treatment Considerations

  • For optimal effectiveness, Avamys should be used at regular intervals rather than on an as-needed basis 1
  • If nasal symptoms are not adequately controlled with the initial dose, increasing to 2 sprays per nostril once daily may be considered for children 8-11 years 1
  • Proper administration technique should be demonstrated to ensure effective delivery and minimize side effects 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Intranasal Steroid Recommendations for Allergic Rhinitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.